Saúde Pública/Medicina Humanitária
Diretriz de Posicionamento AAN | Perspectivas éticas sobre custo de medicamentos e cuidados em saúde.
5 Out, 2021 | 11:22hEthical Perspectives on Costly Drugs and Health Care: AAN Position Statement – Neurology
Comunicado de imprensa: AAN Issues Ethics Position Statement on Costly Drugs and Health Care – American Academy of Neurology
[Comunicado de imprensa – ainda não publicado] Merck anuncia que o antiviral oral Molnupiravir reduziu o risco de internação ou morte em cerca de 50%, comparado ao placebo, em pacientes com COVID-19 leve ou moderada.
4 Out, 2021 | 10:38hComentários:
Expert reaction to interim analysis of oral antiviral molnupiravir – Science Media Centre
Covid antiviral pill can halve risk of hospitalization – BBC
Why Merck’s Covid-19 pill molnupiravir could be so important – Vox
Comentários no Twitter
.@DrEricDing convinced many that stopping the #molnupiravir trial early for benefit was a good idea
But it was NOT
Large body of evidence suggests that stopping early for benefit biases the results: overestimates the benefits of the treatment #EBM https://t.co/b3tHEtliO0 https://t.co/LwuCgqcY0C pic.twitter.com/vyPWc0nd37
— Kari Tikkinen (@KariTikkinen) October 2, 2021
(fio – clique para saber mais)
💡BREAKING—New oral anti-viral drug *molnupiravir* cuts risk of #COVID19 hospitalization and death **in HALF** in a randomized trial. Results so astounding that the trial is being stopped early, and Merck plans to apply for emergency authorization ASAP. 🧵 https://t.co/g8JGNzvuRg pic.twitter.com/K1SwC3QFXS
— Eric Feigl-Ding (@DrEricDing) October 1, 2021
A pandemia arrefecerá até se tornar uma doença comum, como a gripe? O mundo está observando a Dinamarca para ter pistas.
4 Out, 2021 | 10:34h[Preprint] Avaliação do impacto da COVID-19 nos países em desenvolvimento: revisão sistemática, metanálise e implicações de políticas públicas.
4 Out, 2021 | 10:33h
Comentário no Twitter
Our big new study on the infection fatality rate of COVID-19 in developing countries is out
The news is pretty grim 🧵https://t.co/woX4ijWOQy
— Health Nerd (@GidMK) October 2, 2021
Editorial | Ética clínica: consentimento para vacinação de crianças.
4 Out, 2021 | 10:32hClinical ethics: consent for vaccination in children – Archives of Disease in Childhood
Nova análise mostra que os benefícios de se aplicar 2 doses de vacina contra COVID-19 em crianças de 12 a 17 anos supera os riscos.
4 Out, 2021 | 10:30hComunicado de imprensa: New analysis shows benefits of offering two doses of COVID-19 vaccine to children aged 12-17 clearly outweigh risks – The Royal Society of Medicine
Relatório original: Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis
Contéudo relacionado: Covid: Single jab recommended for 12 to 15-year-olds by UK’s top doctors.
Editorial | Vacinação contra Covid-19: evidência de queda na imunidade é exagerada.
4 Out, 2021 | 10:29hCovid-19 vaccination: evidence of waning immunity is overstated – The BMJ
Conteúdos relacionados:
COVID vaccine effects wane over time but still prevent death and severe illness.
Perspective | What we actually know about waning immunity.
Another study shows Pfizer mRNA vaccine immunity is reduced over time.
Studies: COVID vaccine protection waning against infection but not hospitalization.
Pfizer says it’s time for a Covid booster; FDA and CDC say not so fast.
OMS prioriza o acesso a tratamentos de diabetes e câncer na nova Lista de Medicamentos Essenciais.
4 Out, 2021 | 10:25hComunicado de imprensa: WHO prioritizes access to diabetes and cancer treatments in new Essential Medicines Lists – World Health Organization
Relatório: WHO model list of essential medicines – 22nd list, 2021 – World Health Organization
Comentário: For the first time, WHO committee recommends action on high-priced essential medicines – STAT
Comentário no Twitter (fio – clique para saber mais)
🆕 WHO 2021 Essential Medicines Lists have 20 new medicines for adults & 17 for children, incl. insulin analogues, new oral medicines for diabetes & medicines for cancer treatment https://t.co/LfWwHEZtuM pic.twitter.com/HMFOP8ioBf
— World Health Organization (WHO) (@WHO) October 1, 2021
Bem-estar do médico 2.0: onde estamos e para onde vamos?
4 Out, 2021 | 10:19hPhysician Well-being 2.0: Where Are We and Where Are We Going? – Mayo Clinic Proceedings
Conteúdos relacionados:
[Abstract Only] Assessment of Risk Factors for Suicide Among US Health Care Professionals
Beyond Burnout: Docs Decry ‘Moral Injury’ From Financial Pressures of Health Care
Perspective: Hospital Administration Response to Physician Stress and Burnout
Opinion: It’s Time to Talk About Physician Burnout and Moral Injury
Systematic Review: Effect of Organization-Directed Workplace Interventions on Physician Burnout
Perspective: The 3 Causes Of Physician Burnout (And Why There’s No Simple Solution)
Physician Burnout: A Global Crisis (várias fontes sobre o tema)
Testagem eficiente e direcionada de COVID-19 nas fronteiras via inteligência artificial.
1 Out, 2021 | 22:01hEfficient and targeted COVID-19 border testing via reinforcement learning – Nature
Editorial: Greece used AI to curb COVID: what other nations can learn – Nature
Comentário: An algorithm may have helped slow the spread of COVID-19 in Greece – University of Southern California
Comentário no Twitter
A @Nature paper describes Eva, a learning system that led to targeted SARS-CoV-2 testing of travellers arriving in Greece. It identified nearly twice as many asymptomatic, infected people than would be expected for random testing or entry restrictions. https://t.co/Xogj5l4KCS pic.twitter.com/VT5HcXN3ic
— Nature Portfolio (@NaturePortfolio) September 22, 2021


